The emergence of clinical resistance to tigecycline

International Journal of Antimicrobial Agents

Volumn 41, Issue 2, 2013, Pages 110-116

  Sun, Yan ^a   Cai, Yun ^a   Liu, Xu ^a   Bai, Nan ^a   Liang, Beibei ^a   Wang, Rui ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Mechanism; Multidrug resistance; Tigecycline

Indexed keywords

ACRAB PROTEIN; BACTERIAL PROTEIN; CARBAPENEM; RAMA PROTEIN; RAMR PROTEIN; TIGECYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; DRUG EFFICACY; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SERRATIA MARCESCENS; STENOTROPHOMONAS MALTOPHILIA; UPREGULATION;

EID: 84872332948     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.09.005     Document Type: Short Survey

References (86)

1. 2+ cleavage of 16S rRNA J Antimicrob Chemother 53 2004 592 599 (Pubitemid 38499772)
2. + antiporter Antimicrob Agents Chemother 39 1995 247 249
3. K.K. Kumarasamy, M.A. Toleman, T.R. Walsh, J. Bagaria, F. Butt, and R. Balakrishnan Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study Lancet Infect Dis 10 2010 597 602
4. D. Yahav, A. Lador, M. Paul, and L. Leibovici Efficacy and safety of tigecycline: a systematic review and meta-analysis J Antimicrob Chemother 66 2011 1963 1971
5. G. Werner, S. Gfrörer, C. Fleige, W. Witte, and I. Klare Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient J Antimicrob Chemother 61 2008 1182 1183 (Pubitemid 351524469)
6. C. Rodríguez-Avial, I. Rodríguez-Avial, P. Merino, and J.J. Picazo Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient Clin Microbiol Infect 18 2012 61 66
7. I.K. Neonakis, K. Stylianou, E. Daphnis, and S. Maraki First case of resistance to tigecycline by Klebsiella pneumoniae in a European university hospital Indian J Med Microbiol 29 2011 78 79
8. N.S. Al-Qadheeb, S. Althawadi, A. Alkhalaf, S. Hosaini, and A.A. Alrajhi Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient Ann Saudi Med 30 2010 404 407
9. M. Hornsey, N. Loman, D.W. Wareham, M.J. Ellington, M.J. Pallen, and J.F. Turton Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy J Antimicrob Chemother 66 2011 1499 1503
10. L.Y. Chen, T.C. Chen, Y.H. Chen, C.Y. Lin, W.R. Lin, and P.L. Lu Microbial isolation and emergence of antimicrobial resistance associated with tigecycline usage J Microbiol Immunol Infect 44 2011 352 357
11. P. Kopterides, C. Papageorgiou, A. Antoniadou, E. Papadomichelakis, I. Tsangaris, and I. Dimopoulou Failure of tigecycline to treat severe Clostridium difficile infection Anaesth Intensive Care 38 2010 755 758
12. J.C. Gallagher, and H.M. Rouse Tigecycline for the treatment of Acinetobacter infections: a case series Ann Pharmacother 42 2008 1188 1194
13. G.E. Reid, S.A. Grim, C.A. Aldeza, W.M. Janda, and N.M. Clark Rapid development of Acinetobacter baumannii resistance to tigecycline Pharmacotherapy 27 2007 1198 1201 (Pubitemid 47173663)
14. A.Y. Peleg, B.A. Potoski, R. Rea, J. Adams, J. Sethi, and B. Capitano Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report J Antimicrob Chemother 59 2007 128 131 (Pubitemid 46017915)
15. K.B. Anthony, N.O. Fishman, D.R. Linkin, L.B. Gasink, P.H. Edelstein, and E. Lautenbach Clinical and microbiological outcomes of serious infections with multidrug-resistant Gram-negative organisms treated with tigecycline Clin Infect Dis 46 2008 567 570 (Pubitemid 351263497)
16. C. Daurel, A.L. Fiant, S. Brémont, P. Courvalin, and R. Leclercq Emergence of an Enterobacter hormaechei strain with reduced susceptibility to tigecycline under tigecycline therapy Antimicrob Agents Chemother 53 2009 4953 4954
17. J.E. Sherwood, S. Fraser, D.M. Citron, H. Wexler, G. Blakely, and K. Jobling Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan Anaerobe 17 2011 152 155
18. H. Aliskan, F. Can, M. Demirbilek, S. Colakoglu, S. Kilic, and H. Arslan Determining in vitro synergistic activities of tigecycline with several other antibiotics against Brucella melitensis using checkerboard and time-kill assays J Chemother 21 2009 24 30
19. M. Dizbay, D.K. Tozlu, M.Y. Cirak, Y. Isik, K. Ozdemir, and D. Arman In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii J Antibiot (Tokyo) 63 2010 51 53
20. J.M. Entenza, and P. Moreillon Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies Int J Antimicrob Agents 34 2009 8e1 89e
21. N. Taneja, G. Singh, M. Singh, and M. Sharma Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India Indian J Med Res 133 2011 681 684
22. N. Al Sweih, M.F. Salama, W. Jamal, G. Al Hashem, and V.O. Rotimi An outbreak of CTX-M-15-producing Klebsiella pneumoniae isolates in an intensive care unit of a teaching hospital in Kuwait Indian J Med Microbiol 29 2011 130 135
23. A. Manoharan, S. Chatterjee, S. Madhan, and D. Madthai Evaluation of tigecycline activity in clinical isolates among Indian medical centers Indian J Pathol Microbiol 53 2010 734 737
24. C.K. Kim, Y. Lee, H. Lee, G.J. Woo, W. Song, and M.N. Kim Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182 Diagn Microbiol Infect Dis 68 2010 432 438
25. K.C. Chang, M.F. Lin, N.T. Lin, W.J. Wu, H.Y. Kuo, and T.Y. Lin Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan J Microbiol Immunol Infect 45 2012 37 42
26. M. Dizbay, A. Altuncekic, B.E. Sezer, K. Ozdemir, and D. Arman Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia Int J Antimicrob Agents 32 2008 29 32
27. S. Navon-Venezia, A. Leavitt, and Y. Carmeli High tigecycline resistance in multidrug-resistant Acinetobacter baumannii J Antimicrob Chemother 59 2007 772 774 (Pubitemid 47078722)
28. Y.T. Lee, L.Y. Huang, D.H. Chiang, C.P. Chen, T.L. Chen, and F.D. Wang Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan Int J Antimicrob Agents 34 2009 580 584
29. B. Behera, A. Das, P. Mathur, A. Kapil, R. Gadepalli, and B. Dhawan Tigecycline susceptibility report from an Indian tertiary care hospital Indian J Med Res 129 2009 446 450
30. J.W. Liu, L.S. Wang, Y.J. Cheng, G.J. Hsu, P.L. Lu, and Y.C. Liu In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan Int J Antimicrob Agents 32 Suppl. 3 2008 S188 S191
31. N.A. Al-Sweih, M.A. Al-Hubail, and V.O. Rotimi Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals J Chemother 23 2011 13 16
32. S. Tiengrim, C. Tribuddharat, and V. Thamlikitkul In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand J Med Assoc Thai 89 Suppl. 5 2006 S102 S105
33. G.F. Araj, and G.Y. Ibrahim Tigecycline in vitro activity against commonly encountered multidrug-resistant Gram-negative pathogens in a Middle Eastern country Diagn Microbiol Infect Dis 62 2008 411 415
34. Y.K. Park, J.Y. Choi, J.H. Song, and K.S. Ko In vitro activity of tigecycline against colistin-resistant Acinetobacter spp. isolates from Korea Int J Antimicrob Agents 33 2009 289 290
35. R.E. Mendes, D.J. Farrell, H.S. Sader, and R.N. Jones Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp, (2005-2009) Diagn Microbiol Infect Dis 68 2010 307 311
36. A. Capone, S. D'Arezzo, P. Visca, and N. Petrosillo In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii J Antimicrob Chemother 62 2008 422 423 (Pubitemid 351984792)
37. R. Ricciardi, A.M. Ricciardi, and G. Danzi In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates Infez Med 17 2009 236 239
38. H. Seifert, D. Stefanik, and H. Wisplinghoff Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates J Antimicrob Chemother 58 2006 1099 1100
39. R. Insa, E. Cercenado, M.J. Goyanes, A. Morente, and E. Bouza In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia J Antimicrob Chemother 59 2007 583 585 (Pubitemid 47073476)
40. M.H. Scheetz, C. Qi, J.R. Warren, M.J. Postelnick, T. Zembower, and A. Obias In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii Antimicrob Agents Chemother 51 2007 1621 1626 (Pubitemid 46744136)
41. E. Garza-González, J.M. Llaca-Díaz, F.J. Bosques-Padilla, and G.M. González Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii Chemotherapy 56 2010 275 279
42. C.P. García, L.C. Juliet, V.A. Fernández, S.M. San Martín, D.M. Cifuentes, and T.L. Porte Multicenter study on the monitoring of in vitro susceptibility to tigecycline in Santiago, Chile Rev Chilena Infectol 26 2009 220 226 [in Spanish]
43. D.M. Livermore, M. Warner, S. Mushtaq, M. Doumith, J. Zhang, and N. Woodford What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline Int J Antimicrob Agents 37 2011 415 419
44. M.E. Falagas, S. Maraki, D.E. Karageorgopoulos, A.C. Kastoris, E. Mavromanolakis, and G. Samonis Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin Int J Antimicrob Agents 35 2010 240 243
45. I.C. Liao, H.M. Chen, J.J. Wu, P.F. Tsai, L.R. Wang, and J.J. Yan Metallo-β-lactamase-producing Enterobacteriaceae isolates at a Taiwanese hospital: lack of distinctive phenotypes for screening APMIS 119 2011 543 550
46. J.D. Perry, S.H. Naqvi, I.A. Mirza, S.A. Alizai, A. Hussain, and S. Ghirardi Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media J Antimicrob Chemother 66 2011 2288 2294
47. M. Castanheira, H.S. Sader, and R.N. Jones Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae Microb Drug Resist 16 2010 61 65
48. N. Woodford, R.L. Hill, and D.M. Livermore In vitro activity of tigecycline against carbapenem-susceptible and -resistant isolates of Klebsiella spp. and Enterobacter spp. J Antimicrob Chemother 59 2007 582 583 (Pubitemid 47073475)
49. R. Naesens, J.P. Ursi, J. Van Schaeren, and A. Jeurissen In vitro activity of tigecycline against multidrug-resistant Enterobacteriaceae isolates from a Belgian hospital Eur J Clin Microbiol Infect Dis 28 2009 381 384
50. M.S. Hsu, C.H. Liao, C.Y. Liu, C.J. Yang, Y.T. Huang, and P.R. Hsueh In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents Int J Antimicrob Agents 37 2011 276 278
51. P.R. Lagacé-Wiens, P.J. Simner, K.R. Forward, F. Tailor, H.J. Adam, and M. Decorby Canadian Antimicrobial Resistance Alliance (CARA). Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada - results of the CANWARD 2007-2009 study Diagn Microbiol Infect Dis 69 2011 314 319
52. S. Grandesso, B. Sapino, S. Mazzucato, R. Alessandrini, M. Solinas, and M. Gion Study on in vitro susceptibility of ESBL-positive Escherichia coli isolated from urine specimens Infez Med 18 2010 162 168 [in Italian]
53. A. Sekowska, and E. Gospodarek Susceptibility of Klebsiella spp. to tigecycline and other selected antibiotics Med Sci Monit 16 2010 BR193 BR196
54. B. Berçot, L. Poirel, L. Dortet, and P. Nordmann In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae J Antimicrob Chemother 66 2011 2295 2297
55. M.F. Vázquez, E.D. Romero, M.I. García, J.A. Rodríguez, and J.L. Bellido Comparative in vitro activity of tigecycline against enterobacteria producing two or more extended-spectrum β-lactamases Int J Antimicrob Agents 32 2008 541 543
56. J.R. DiPersio, and M.J. Dowzicky Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial Int J Antimicrob Agents 29 2007 518 527 (Pubitemid 46560368)
57. D.R. Snydman, N.V. Jacobus, L.A. McDermott, Y. Golan, E.J. Goldstein, and L. Harrell Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009 Anaerobe 17 2011 147 151
58. J.A. Karlowsky, A.J. Walkty, H.J. Adam, M.R. Baxter, D.J. Hoban, and G.G. Zhanel Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study Antimicrob Agents Chemother 56 2012 1247 1252
59. E. Nagy, E. Urbán, C.E. Nord ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience Clin Microbiol Infect 17 2011 371 379
60. R. Zhang, Q. Sun, Y.J. Hu, H. Yu, Y. Li, and Q. Shen Detection of the Smqnr quinolone protection gene and its prevalence in clinical isolates of Stenotrophomonas maltophilia in China J Med Microbiol 61 2012 535 539
61. H. Wu, J.T. Wang, Y.R. Shiau, H.Y. Wang, T.L. Lauderdale, and S.C. Chang A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan J Microbiol Immunol Infect 45 2012 120 126
62. E.J. Verkade, C.J. Verhulst, X.W. Huijsdens, and J.A. Kluytmans In vitro activity of tigecycline against methicillin-resistant Staphylococcus aureus, including livestock-associated strains Eur J Clin Microbiol Infect Dis 29 2010 503 507
63. M. Kresken, K. Becker, H. Seifert, E. Leitner, B. Körber-Irrgang, and C. von Eiff Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany Eur J Clin Microbiol Infect Dis 30 2011 1095 1103
64. F. Tubau, J. Liñares, M.D. Rodríguez, E. Cercenado, M.J. Aldea, and F. González-Romo Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery Diagn Microbiol Infect Dis 66 2010 308 313
65. A. Darabi, D. Hocquet, and M.J. Dowzicky Antimicrobial activity against Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2004 and 2008 as part of the Tigecycline Evaluation and Surveillance Trial Diagn Microbiol Infect Dis 67 2010 78 86
66. C.R. Dean, M.A. Visalli, S.J. Projan, P.E. Sum, and P.A. Bradford Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1 Antimicrob Agents Chemother 47 2003 972 978 (Pubitemid 36254223)
67. M.A. Visalli, E. Murphy, S.J. Projan, and P.A. Bradford AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis Antimicrob Agents Chemother 47 2003 665 669 (Pubitemid 36158098)
68. R. Rajendran, R.F. Quinn, C. Murray, E. McCulloch, C. Williams, and G. Ramage Efflux pumps may play a role in tigecycline resistance in Burkholderia species Int J Antimicrob Agents 36 2010 151 154
69. T. Hirata, A. Saito, K. Nishino, N. Tamura, and A. Yamaguchi Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936) Antimicrob Agents Chemother 48 2004 2179 2184 (Pubitemid 38691616)
70. D. Keeney, A. Ruzin, F. McAleese, E. Murphy, and P.A. Bradford MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli J Antimicrob Chemother 61 2008 46 53
71. M. Hentschke, M. Christner, I. Sobottka, M. Aepfelbacher, and H. Rohde Combined ramR mutation and presence of a Tn1721-associated tet(A) variant in a clinical isolate of Salmonella enterica serovar Hadar resistant to tigecycline Antimicrob Agents Chemother 54 2010 1319 1322
72. T. Horiyama, E. Nikaido, A. Yamaguchi, and K. Nishino Roles of Salmonella multidrug efflux pumps in tigecycline resistance J Antimicrob Chemother 66 2011 105 110
73. A. Ruzin, M.A. Visalli, D. Keeney, and P.A. Bradford Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae Antimicrob Agents Chemother 49 2005 1017 1022 (Pubitemid 40327718)
74. S. Bratu, D. Landman, A. George, J. Salvani, and J. Quale Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City J Antimicrob Chemother 64 2009 278 283
75. R. Rosenblum, E. Khan, G. Gonzalez, R. Hasan, and T. Schneiders Genetic regulation of the ramA locus and its expression in clinical isolates of Klebsiella pneumoniae Int J Antimicrob Agents 38 2011 39 45
76. D. Keeney, A. Ruzin, and P.A. Bradford RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae Microb Drug Resist 13 2007 1 6 (Pubitemid 46833752)
77. M. Hornsey, M.J. Ellington, M. Doumith, G. Scott, D.M. Livermore, and N. Woodford Emergence of AcrAB-mediated tigecycline resistance in a clinical isolate of Enterobacter cloacae during ciprofloxacin treatment Int J Antimicrob Agents 35 2010 478 481
78. M. Hentschke, M. Wolters, I. Sobottka, H. Rohde, and M. Aepfelbacher ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline Antimicrob Agents Chemother 54 2010 2720 2723
79. A.Y. Peleg, J. Adams, and D.L. Paterson Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii Antimicrob Agents Chemother 51 2007 2065 2069 (Pubitemid 46903095)
80. J.R. Sun, M.C. Chan, T.Y. Chang, W.Y. Wang, and T.S. Chiueh Overexpression of the adeB gene in clinical isolates of tigecycline- nonsusceptible Acinetobacter baumannii without insertion mutations in adeRS Antimicrob Agents Chemother 54 2010 4934 4938
81. A. Ruzin, F.W. Immermann, and P.A. Bradford RT-PCR and statistical analyses of adeABC expression in clinical isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex Microb Drug Resist 16 2010 87 89
82. M. Hornsey, M.J. Ellington, M. Doumith, S. Hudson, D.M. Livermore, and N. Woodford Tigecycline resistance in Serratia marcescens associated with up-regulation of the SdeXY-HasF efflux system also active against ciprofloxacin and cefpirome J Antimicrob Chemother 65 2010 479 482
83. I.F. Moore, D.W. Hughes, and G.D. Wright Tigecycline is modified by the flavin-dependent monooxygenase TetX Biochemistry 44 2005 11829 11835 (Pubitemid 41262717)
84. N.A. Bartha, J. Sóki, E. Urbán, and E. Nagy Investigation of the prevalence of tetQ, tetX and tetX1 genes in Bacteroides strains with elevated tigecycline minimum inhibitory concentrations Int J Antimicrob Agents 38 2011 522 525
85. G. Volkers, G.J. Palm, M.S. Weiss, G.D. Wright, and W. Hinrichs Structural basis for a new tetracycline resistance mechanism relying on the TetX monooxygenase FEBS Lett 585 2011 1061 1066
86. F. McAleese, P. Petersen, A. Ruzin, P.M. Dunman, E. Murphy, and S.J. Projan A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline Antimicrob Agents Chemother 49 2005 1865 1871 (Pubitemid 40631601)